Efficacy and safety of doxazosin in hypertension therapy

The American Journal of Cardiology

Volumn 59, Issue 14, 1987, Pages

  Hayduk, Karl ^a  

^a MARIEN HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; HYDROCHLOROTHIAZIDE; METOPROLOL; NADOLOL; PLACEBO; PRAZOSIN; TERAZOSIN;

ADVERSE DRUG REACTION; CARDIOVASCULAR SYSTEM; DRUG COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MITOPROLOL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; THERAPY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DOXAZOSIN; FEMALE; HEART RATE; HUMAN; HYPERTENSION; LIPIDS; MALE; MIDDLE AGE; PRAZOSIN;

EID: 0023228390     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(87)90155-X     Document Type: Article

References (11)

1. Recommendations for treatment of hypertension
2. Selection of initial antihypertensive therapy New perspectives on coronary heart disease risk factors provide new insights
3. Summary of prazosin lipid studies
4. Application of pharmacokinetic-pharmacodynamic modelling for the comparison of quinazoline α-adrenoceptor agonists in normotensive volunteers
5. The metabolism and kinetics of doxazosin in man mouse rat and dog
6. The antihypertensive effects of doxazosin a clinical overview
7. Antihypertensive effect of doxazosin in hypertensive patients comparison with terazosin
8. A multicenter trial of doxazosin in West Germany
9. Antihypertensive effect of doxazosin in hypertensive patients comparison with atenolol
10. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension
11. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins